Summary:
- ProQR, a biotechnology company, has announced a partnership with Ginkgo Bioworks, a leading synthetic biology company. This partnership aims to leverage Ginkgo's expertise in artificial intelligence (AI) and machine learning to enhance ProQR's drug discovery and development processes.
- ProQR has also formed an AI Advisory Board, which will provide strategic guidance and oversight on the company's use of AI and machine learning technologies. This board will help ensure that ProQR's AI initiatives are aligned with its overall business objectives and scientific priorities.
- The collaboration between ProQR and Ginkgo Bioworks, as well as the formation of the AI Advisory Board, demonstrate the growing importance of AI and machine learning in the biotechnology industry. These advancements can accelerate the discovery and development of new drugs, ultimately benefiting patients in need.